High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML

Completed · Phase 2

Conditions studied: Myelodysplastic Syndrome, Acute Myeloid Leukemia

In brief

The purpose of this study is to determine the effectiveness of a particular combination of drugs used to treat cancer.

Key facts

Study ID

NCT00774046

Run by

University of Chicago

People needed

32

Starts

2002-12-01

Expected to finish

2011-03-01

Last updated by the study team

2014-02-11

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have received cytotoxic chemotherapy,radiation,or a drug known to affect the properties of DNA or cell growth for some condition other than acute myeloid leukemia prior to diagnosis.
• Patients must have t-MDS/t-AML
• To be eligible for allogeneic transplantation, patients must have a suitable donor who is HLA compatible.
• Patients must be over the age of 10.
• Patients must be reviewed and discussed at the Leukemia and Transplant Conferences of the Section of Hematology/Oncology.

You may not qualify if…

• Patients must not have any other serious medical condition(e.g.uncontrolled or severe cardiovascular disease, diabetes, pulmonary disease, or infection)
• Psychiatric condition which would prevent compliance or possibly be worsened by treatment

Where it is running

• The University of Chicago — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.